Project Number 3U01AG028713-03S1 Agency/Funding Organization NIA Funding Year 2010 View Full Project Details for CALPAIN INHIBITORS AGAINST ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator ARANCIO, OTTAVIO Principal Investigator First Name OTTAVIO Principal Investigator Last Name ARANCIO Awardee Organization COLUMBIA UNIVERSITY Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-05-148: Alzheimer's Disease Drug Development Program FY Overall Cost $33,468 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official BUCKHOLTZ, NEIL Related Resources Repository [AlzPED] Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer’s Disease Patent Cysteine protease inhibitors and uses thereof
